Nu Skin Enterprises (NYSE:NUS) Raised to “Buy” at StockNews.com

Nu Skin Enterprises (NYSE:NUS) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Friday.

A number of other equities analysts also recently weighed in on NUS. Citigroup cut their target price on Nu Skin Enterprises from $14.00 to $11.50 and set a “neutral” rating on the stock in a research note on Friday, August 9th. DA Davidson cut their target price on Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating on the stock in a research note on Monday, August 12th. Three analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $16.50.

Nu Skin Enterprises Stock Down 4.1 %

NUS stock traded down $0.34 during mid-day trading on Friday, reaching $8.01. 699,836 shares of the company traded hands, compared to its average volume of 745,415. The stock has a market cap of $397.83 million, a price-to-earnings ratio of -133.50 and a beta of 1.13. The company has a quick ratio of 1.33, a current ratio of 2.12 and a debt-to-equity ratio of 0.62. Nu Skin Enterprises has a fifty-two week low of $8.00 and a fifty-two week high of $24.38. The firm’s 50 day moving average price is $10.09 and its 200 day moving average price is $11.83.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.04. Nu Skin Enterprises had a positive return on equity of 7.80% and a negative net margin of 8.05%. The business had revenue of $439.10 million during the quarter, compared to the consensus estimate of $431.87 million. During the same quarter in the previous year, the business earned $0.54 EPS. The company’s quarterly revenue was down 12.2% on a year-over-year basis. As a group, equities research analysts predict that Nu Skin Enterprises will post 0.78 EPS for the current fiscal year.

Hedge Funds Weigh In On Nu Skin Enterprises

Several institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in Nu Skin Enterprises by 4.4% in the first quarter. Vanguard Group Inc. now owns 6,489,580 shares of the company’s stock valued at $89,751,000 after purchasing an additional 274,309 shares during the last quarter. Pacer Advisors Inc. bought a new stake in Nu Skin Enterprises during the 2nd quarter valued at $25,230,000. Federated Hermes Inc. raised its holdings in Nu Skin Enterprises by 111.8% during the 2nd quarter. Federated Hermes Inc. now owns 1,323,542 shares of the company’s stock valued at $13,950,000 after acquiring an additional 698,722 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in Nu Skin Enterprises by 17.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,157,697 shares of the company’s stock valued at $22,482,000 after acquiring an additional 173,193 shares during the period. Finally, Bank of New York Mellon Corp raised its holdings in Nu Skin Enterprises by 5.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 901,098 shares of the company’s stock valued at $9,498,000 after acquiring an additional 43,935 shares during the period. Hedge funds and other institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.